Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 2009
published in
has subject area
- Aged
- Alzheimer Disease
- Central Nervous System Depressants
- Circadian Rhythm
- Double-Blind Method
- Drug Administration Schedule
- Drug Evaluation
- Geriatric Assessment
- Humans
- Melatonin
- Nursing Homes
- Placebos
- Polysomnography
- Psychiatric Status Rating Scales
- Psychomotor Agitation
- Severity of Illness Index
- Sleep Wake Disorders